Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritis

Clinical Rheumatology

Volumn 26, Issue 11, 2007, Pages 1819-1823

  Sabry, Alaa ^a,b   Sheashaa, Hussein ^a   El Husseini, Amr ^a   El Dahshan, Khaled ^a   Abdel Rahim, Mona ^a   Elbasyouni, Sherief Refat ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

ICAM 1; Lupusnephritis; SLE

Indexed keywords

BIOLOGICAL MARKER; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE MARKER; EGYPT; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MICROSCOPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 34948875327     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0580-7     Document Type: Article

References (29)

1. Barr SG, Zonana-Nacach A, Magder LS, Petri M (1999) Patterns of disease activity in systemic lupus erythmatosis. Arthritis Rheum 42:2682-2688
2. Ross R (1999) Atherosclerosis: An inflammatory disease. N Engl J Med 14:340(2):115-126
3. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387-1397
4. Lowe GD, Rumley A, McMahon AD, Ford IO, Reilly DS, Packard CJ (2004) Interleukin-6, fibrin D-dimer, and coagulation factors V11 and X11a in prediction of coronary heart disease. Arterioscler Thromb Vasc Biol 24(10):1957-1962
5. Sari RA, Taysi S, Erdem F, Yilmaz O, Keles S, Kiziltunc A, Odabas AR, Cetinkaya R (2002) Correlation of serum levels of soluble intercellular adhesion molecule-1 with disease activity in systemic lupus erythematosus. Rheumatol Int 21(4):149-152
6. Blankberg S, barbaux S, Tiret L (2003) Adhesion molecules and atherosclerosis. Atherosclerosis 170(2):191-203
7. Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271-1277
8. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630-640
9. Papagianni A, Kalovoulos M, Kirmizis D et al (2003) Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol Dial Transplant 18:113-119
10. Madaio MP (1998) The role of autoantibodies in the pathogenesis of lupus nephritis. Immunol Res 17(1-2):123-132
11. Huong DL, Papo T, Beaufils H et al (1999) Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine (Baltimore) 78(3):148-166
12. Bjornadal L, Yin L, Granath F, Klareskog L, Ekbom A (2004) Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: Results from a Swedish population based study 1964-95. J Rheumatol 31(4):713-719
13. Hurlimann D, Enseleit F, Ruschitzka F (2004) Rheumatoid arthritis, inflammation, and atherosclerosis. Herz 29(8):760-768
14. Lacki JK, Leszczynski P, Kelemen J, Muller W, Mackiewicz SH (1997) Cytokine concentration in serum of lupus erythmatosus patients: The effect on acute phase response. J Med 28(1-2):99-107
15. Sinisalo J, Paronen J, Mattila KJ, Syrjala M, Alfthan G, Palosuo T, Nieminen MS, Vaarala O (2000) Relation of inflammation to vascular function in patients with coronary heart disease. Atherosclerosis 149(2):403-411
16. O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE (1996) Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93(4):672-682
17. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimburger O, Cederholm T, Girndt M (2005) IL-10, IL-6, and TNF-alpha: Central factors in the altered cytokine network of uremia - the good, the bad, and the ugly. Kidney Int 67(4):1216-1233
18. Rohde LE, Lee RT, Rivero J et al (1998) Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 18(11):1765-1770
19. Malik I, Danesh J, Whincup P, Bhatia V, Papacosta O, Walker M, Lennon L, Thomson A, Haskard D (2001) Soluble adhesion molecules and prediction of coronary heart disease: A prospective study and meta-analysis. Lancet 358:971-976
20. Zaccagni H, Fried J, Cornell J, Padilla P, Brey RL (2004) Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage. Front Biosci 1;9:1654-1659
21. Laucella SA, Gaddi E, Balbaryski J, Giraudi V, Cuttica RJ (1999) Soluble intercellular adhesion molecule-1 in paediatric connective tissue diseases. Acta Paediatr 88(4):399-403
22. Sfikakis PP, Charalambopoulos D, Vayiopoulos G, Oglesby R, Sfikakis P, Tsokos GC (1994) Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus. Clin Exp Rheumatol 12(1):5-9
23. Breedveld FC, van der Lubbe PA (1995) Monoclonal antibody therapy of inflammatory rheumatic diseases. Br Med Bull 51(2):493-502
24. Janssen BA, Luqmani RA, Gordon C, Hemingway IH, Bacon PA, Gearing AJ, Emery P (1994) Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis. Br J Rheumatol 33(12):1112-1116
25. Spronk PE, Bootsma H, Huitema MG, Limburg PC, Kallenberg CG (1994) Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. Clin Exp Immunol 97(3):439-444
26. Suzuki H, Schmid-Schonbein GW, Suematsu M, DeLano FA, Forrest MJ, Miyasaka M et al (1994) Impaired leukocyte-endothelial cell interaction in spontaneously hypertensive rats. Hypertension 24:719-727
27. De Caterina R, Ghiadoni L, Taddei S, Virdis A, Almerigogna F, Basta G et al (2001) Soluble E-selectin in essential hypertension: A correlate of vascular structural changes. Am J Hypertens 14:259-266
28. Liu Y, Liu T, McCarron RM, Spatz M, Feuerstein G, Hallenbeck JM, Siren AL (1996) Evidence for activation of endothelium and monocytes in hypertensive rats. Am J Physiol 270(6 Pt 2):H2125-H2131
29. DeSouza CA, Dengel DR, Macko RF, Cox K, Seals DR (1997) Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension. Am J Hypertens 10(12):1335-1341